Education
About Us
Working with TipRanks
Follow Us
Skane-moellan AB (SE:SKMO)
:SKMO
Top Page
Skane-moellan AB
(SKMO)
Select Model
Select Model
Rating:56Neutral
Price Target:
kr60.00
▲(3.81% Upside)
The score is held up by the company’s very strong, debt-free balance sheet, but is weighed down by multi-year margin compression and volatile/weaker recent free cash flow. The technical setup is bearish (price below key moving averages and negative MACD), and the high P/E (~40) with only a moderate dividend yield provides limited valuation support.
Skane-moellan AB (SKMO) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr629.20M
Dividend Yield2.43%
Average Volume (3M)272.00
Price to Earnings (P/E)39.6
Beta (1Y)-0.23
Revenue GrowthN/A
EPS GrowthN/A
CountrySE
Employees28
SectorServices
Sector StrengthN/A
IndustryPackaged Foods
Share Statistics
EPS (TTM)0.34
Shares Outstanding11,000,000
10 Day Avg. Volume114
30 Day Avg. Volume272
Financial Highlights & Ratios
PEG Ratio3.29
Price to Book (P/B)3.17
Price to Sales (P/S)1.95
P/FCF Ratio38.71
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Skane-moellan AB Business Overview & Revenue Model
Company DescriptionSkåne-möllan AB (publ) engages in the production and sale of flour and cereal products to bakeries, food industries, and consumers in Sweden. It offers organic wheat, organic cut rye, whole grain wheat, bakery wheat, graham, rye, and barley flour products; heat treated grain products; oat flour and oat flakes; and oat kernels. The company sells its flour products under the Möllarens brands. Skåne-möllan AB (publ) was founded in 1971 and is based in Tågarp, Sweden.
How the Company Makes Money
Skane-moellan AB Financial Statement Overview
Summary
Income Statement
Balance Sheet
Cash Flow
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 252.90M | 265.00M | 271.13M | 271.96M | 213.96M | 197.88M |
| Gross Profit | 46.40M | 47.20M | 44.58M | 54.82M | 51.39M | 48.42M |
| EBITDA | 22.10M | 23.20M | 21.70M | 31.02M | 32.59M | 29.78M |
| Net Income | 15.80M | 16.20M | 14.79M | 20.78M | 21.91M | 20.30M |
Balance Sheet | ||||||
| Total Assets | 184.40M | 194.70M | 200.94M | 193.90M | 190.49M | 170.11M |
| Cash, Cash Equivalents and Short-Term Investments | 48.50M | 60.20M | 61.63M | 44.30M | 72.43M | 50.04M |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 32.30M | 31.60M | 38.80M | 31.07M | 33.36M | 21.74M |
| Stockholders Equity | 152.10M | 163.10M | 162.14M | 162.83M | 157.13M | 148.37M |
Cash Flow | ||||||
| Free Cash Flow | 23.60M | 13.36M | 33.72M | -12.35M | 19.29M | 14.89M |
| Operating Cash Flow | 25.10M | 19.80M | 41.03M | -6.78M | 33.37M | 22.57M |
| Investing Cash Flow | -7.00M | -5.80M | -8.31M | -5.94M | 2.22M | -7.30M |
| Financing Cash Flow | 0.00 | -15.40M | -15.40M | -15.40M | -13.20M | -12.10M |
Skane-moellan AB Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | kr584.87M | 27.18 | ― | 0.51% | 22.02% | 127.51% | |
68 Neutral | kr6.44B | 20.80 | ― | 2.56% | 7.37% | 2.90% | |
64 Neutral | kr131.96M | 15.41 | ― | ― | 5.91% | ― | |
61 Neutral | kr740.24M | 20.11 | ― | ― | 34.18% | 242.91% | |
56 Neutral | kr629.20M | 39.57 | ― | 2.43% | ― | ― | |
55 Neutral | $13.29B | 17.42 | 10.03% | 0.93% | 7.13% | -12.93% |
* Services Sector Average
SE:SKMO
Skane-moellan AB
57.20
11.07
24.00%
DE:9KF
Midsona AB Class B
0.78
0.13
20.00%
SE:NNH
New Nordic Healthbrands AB
20.10
5.00
33.11%
SE:SNX
Premium Snacks Nordic AB
43.10
24.42
130.73%
SE:CASE
Case Group AB
23.40
6.00
34.48%
SE:SCST
Scandi Standard AB
97.50
16.60
20.52%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.